Go Back to Ambassador's page

Eugenia Grand

Registered Dietitian and member of the HCPC & BDA

About the Ambassador

Eugenia Grand is a Registered Dietitian and member of the Health & Care Professions Council (HCPC) & the British Dietetic Association (BDA). Eugenia works with patients who may require fertility treatment in the NHS and female patients who need support managing polycystic ovarian syndrome. Eugenia, also specialise in women's health, female and male fertility and pregnancy nutrition.

Eugenia, hold a bachelor’s degree in Natural Sciences from the University of Tartu and a Bachelor of Science Degree in Nutrition & Dietetics from Aberdeen's Robert Gordon University.

Over the last ten years, Eugenia, worked in the NHS and private sectors, and has covered various specialities, including nutritional support in adults, gastroenterology, weight management in children and adults, gestational diabetes and type 2 diabetes prevention and remission, allergies in children, oncology, and nutrition in critically ill (intensive care).

PCOS Relief is delighted to have Eugenia as an Ambassador, her knowledge and experience will allow our members to have right nutritional information, that can support them in having a healthy lifestyle and fertility journey.

Official update · May 2026

A landmark update
for 170 million
women worldwide

Previously PCOS Polycystic Ovary Syndrome
Now officially PMOS Polyendocrine Metabolic Ovarian Syndrome

Published in The Lancet, May 2026 · Endorsed by the Endocrine Society · 56 global organisations

What was PCOS?

A hormonal condition named after the appearance of follicles on the ovaries — a term widely recognised as inaccurate, leading to delayed diagnoses and misunderstood care for millions.

What is PMOS?

A complex, long-term condition involving multiple hormone imbalances, metabolic effects like insulin resistance, and impacts on reproductive, mental, and cardiovascular health — far beyond just the ovaries.

After a decade-long global study with 22,000+ patients and clinicians, the new name was published in The Lancet to reduce diagnostic delays affecting up to 70% of women living with this condition.

Take Survey